Douglas Reed M.D., 10% Owner at G1 Therapeutics, Inc. (GTHX), sold 800,000 shares at $48.00 ($38.4M) on 2018-05-30, disclosed to the SEC on 2018-06-01.
Open-market sale of $38.4M GTHX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.00 | 41,710 | $2.0M | 5.2% |
| 2 | $48.00 | 758,290 | $36.4M | 94.8% |
| Total | $48.00 avg | 800,000 | $38.4M | 100% |
| Filing → |
| CLSD | SELL | 2017-01-19 | $512K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $1000K | — | Filing → |
| DRAD | SELL | 2007-08-27 | $92K | — | Filing → |